Search this site

Discover Synergy Biologics’ quality assurance processes, ensuring GMP-compliant manufacturing, rigorous testing and full regulatory compliance. Delivering consistent, safe and reliable nutraceutical and pharmaceutical products across the UK. Quality Assurance Built-In Quality at Every Stage Quality is embedded throughout the full product life cycle, from raw material sourcing to final release. All ingredients are approved against strict standards before use, and each stage of production is validated before the next begins. Every batch undergoes visual inspection for packaging accuracy and product integrity, followed by third-party microbiological testing prior to market release. Robust Systems and Regulatory Compliance Our operations are supported by an ISO 9001:2015 Quality Management System, ensuring all processes are controlled, documented and compliant with relevant regulatory and HACCP standards. We maintain strict process validation, detailed documentation and continuous staff training. Quality is also preserved beyond manufacturing, with guidance on storage, handling and distribution to support product integrity throughout its shelf life. Continuous Improvement and Customer Confidence We apply ongoing internal and external audits to strengthen both product quality and manufacturing processes. This allows us to continuously improve and respond to evolving standards and expectations. Our commitment to quality supports consistent, reliable products suitable for a wide range of dietary requirements, helping build trust with customers and healthcare professionals alike. Our quality assurance systems support every stage of product development, manufacturing and release, helping ensure products are produced to defined specifications and appropriate quality standards. For brands looking to develop capsules, tablets, liquids, gummies, our quality-led approach provides a strong foundation for reliable nutraceutical manufacturing. UK Nutraceutical Manufacturer for Capsules, Tablets and Gummies

Read the Synergy Biologics Modern Slavery Statement, outlining our commitment to ethical sourcing, supply chain transparency and compliance with UK legislation to prevent modern slavery and human trafficking. Modern Slavery and Human Trafficking Statement Our Commitment to Ethical Business Practices Synergy Biologics Limited is committed to operating responsibly and opposing all forms of modern slavery and human trafficking. As a UK manufacturer, distributor and retailer of nutraceutical and healthcare products, we work with approved suppliers who are assessed against quality, regulatory and ethical standards. Although we are below the reporting threshold under the Modern Slavery Act 2015, we voluntarily publish this statement as part of our commitment to transparency and responsible business practices. Our MHRA WDA(H) and MIA licences further support robust governance, quality assurance and supply chain oversight across our operations. Supporting and Protecting Our Employees We provide employees with guidance on recognising and reporting concerns relating to modern slavery and human trafficking, both within the workplace and wider community. Our Modern Slavery Statement forms part of employee onboarding and internal policies, with confidential whistleblowing and reporting procedures available to all team members. Responsible Supply Chain Oversight We apply due diligence procedures across our supply chain to help identify and reduce potential risks. Supplier approval questionnaires, audits and ongoing assessments are used to review areas including labour standards, safety, legal compliance, environmental responsibility and ethical sourcing. This helps ensure suppliers align with our operational and ethical expectations. Ongoing Review and Accountability We remain committed to monitoring and improving our practices to help prevent modern slavery and human trafficking throughout our operations and supply chain. This statement is reviewed annually and updated where appropriate to reflect operational changes, evolving risks and legislative developments. This statement has been approved by the Board of Directors of Synergy Biologics Limited in accordance with Section 54(6) of the Modern Slavery Act 2015. [September 2025] Robin Deb Managing Director

We can’t find the page you’re looking for This page doesn’t exist. Go to Home and keep exploring. Go to Home